Learn how to improve cell line development

""

Join DDW for this exclusive on-demand event Embedding Quality into Cell Line Development Through the Application of an Innovative Picodroplet-Based Single Cell Sorter, supported by Sphere Fluidics.

Generation of a highly expressing, regulatory acceptable clonal cell line is the first key activity in the development of a biopharmaceutical. Cell line development is labour intensive, time consuming and costly and is subject to stringent regulations to ensure patient safety.

Dr Jonathan H Dempsey
Dr Jonathan H Dempsey

All cell lines used to produce clinical batches of biopharmaceuticals are required to conform to ICH5Q which requires that cell lines are demonstrated to have a traceable history, are clonal and their construction is fully documented.

In this webinar, Dr Jonathan H Dempsey, Managing Director of Dempsey Consulting and Founding Partner of Pathway Biopharma Consulting, describes the implementation of an innovative technology which provides a visual record of clonality, history and clone derivation and also allows for transfected pool enrichment resulting in highly expressing clones.

A comparison of this instrument with existing methods and highlight benefits of traceability and speed from transfection to a clonal cell line is presented.

What you will learn:

  • How to improve quality in cell line development
  • About the application picodroplet technology for single cell analysis
  • How to improve speed and efficiency in cell line development workflows

Register free here.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free